Katherine Elena Economy, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications, Cardiovascular | 16 | 2021 | 500 | 3.150 |
Why?
|
| Delivery, Obstetric | 6 | 2020 | 906 | 1.320 |
Why?
|
| Heart Diseases | 4 | 2021 | 2789 | 0.790 |
Why?
|
| Pregnancy Complications, Hematologic | 3 | 2020 | 183 | 0.620 |
Why?
|
| Pregnancy | 42 | 2024 | 29144 | 0.570 |
Why?
|
| Hematologic Agents | 2 | 2019 | 39 | 0.570 |
Why?
|
| Heart Valve Prosthesis | 4 | 2018 | 1490 | 0.510 |
Why?
|
| Cesarean Section | 3 | 2020 | 1365 | 0.490 |
Why?
|
| Pregnancy Outcome | 8 | 2021 | 2795 | 0.420 |
Why?
|
| Abortion, Induced | 2 | 2024 | 458 | 0.310 |
Why?
|
| Labor, Obstetric | 1 | 2011 | 333 | 0.300 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 2375 | 0.270 |
Why?
|
| Thrombophilia | 2 | 2020 | 305 | 0.260 |
Why?
|
| Pre-Eclampsia | 3 | 2013 | 1200 | 0.260 |
Why?
|
| Gestational Age | 5 | 2020 | 3493 | 0.260 |
Why?
|
| Pregnancy Complications | 6 | 2018 | 2861 | 0.250 |
Why?
|
| American Heart Association | 2 | 2020 | 1057 | 0.240 |
Why?
|
| Cardiology | 1 | 2015 | 1668 | 0.240 |
Why?
|
| Pregnancy Complications, Neoplastic | 3 | 2016 | 255 | 0.240 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 1739 | 0.220 |
Why?
|
| Societies, Medical | 1 | 2015 | 3743 | 0.220 |
Why?
|
| Heart Defects, Congenital | 5 | 2022 | 4583 | 0.220 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2020 | 789 | 0.220 |
Why?
|
| Tetralogy of Fallot | 3 | 2020 | 623 | 0.210 |
Why?
|
| Postnatal Care | 3 | 2020 | 236 | 0.210 |
Why?
|
| Pericarditis | 1 | 2023 | 128 | 0.210 |
Why?
|
| Tocolytic Agents | 1 | 2001 | 25 | 0.200 |
Why?
|
| Prenatal Care | 4 | 2023 | 1092 | 0.200 |
Why?
|
| Female | 46 | 2024 | 380193 | 0.190 |
Why?
|
| Breast Neoplasms | 4 | 2022 | 20824 | 0.180 |
Why?
|
| Heart Rate, Fetal | 1 | 2020 | 75 | 0.180 |
Why?
|
| Extraction, Obstetrical | 1 | 2019 | 26 | 0.170 |
Why?
|
| Connective Tissue Diseases | 2 | 2019 | 264 | 0.170 |
Why?
|
| Registries | 1 | 2015 | 8091 | 0.170 |
Why?
|
| Infant, Newborn | 9 | 2022 | 25628 | 0.170 |
Why?
|
| Valsalva Maneuver | 1 | 2019 | 92 | 0.170 |
Why?
|
| Fibrinolytic Agents | 2 | 2020 | 2158 | 0.160 |
Why?
|
| Fetal Heart | 1 | 2020 | 276 | 0.160 |
Why?
|
| Amenorrhea | 1 | 2002 | 485 | 0.160 |
Why?
|
| Calcium Channel Blockers | 1 | 2001 | 692 | 0.160 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2019 | 2269 | 0.150 |
Why?
|
| Blood Pressure | 1 | 2013 | 8551 | 0.150 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2020 | 440 | 0.150 |
Why?
|
| Prospective Studies | 6 | 2023 | 53290 | 0.150 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2020 | 456 | 0.150 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2020 | 263 | 0.150 |
Why?
|
| Breast Feeding | 2 | 2023 | 1338 | 0.150 |
Why?
|
| Pheochromocytoma | 2 | 2009 | 337 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 15160 | 0.150 |
Why?
|
| Pelvic Pain | 1 | 1999 | 274 | 0.150 |
Why?
|
| Risk Adjustment | 1 | 2020 | 594 | 0.140 |
Why?
|
| Vagina | 1 | 2002 | 825 | 0.140 |
Why?
|
| Anesthetics | 1 | 2022 | 539 | 0.140 |
Why?
|
| Hemorrhage | 2 | 2020 | 3461 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2024 | 831 | 0.140 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2015 | 31 | 0.140 |
Why?
|
| Postpartum Hemorrhage | 1 | 2019 | 258 | 0.130 |
Why?
|
| Cardiovascular Agents | 2 | 2019 | 850 | 0.130 |
Why?
|
| Pulmonary Edema | 4 | 2014 | 414 | 0.130 |
Why?
|
| Humans | 46 | 2024 | 744366 | 0.130 |
Why?
|
| Heart Ventricles | 2 | 2020 | 3817 | 0.120 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 314 | 0.120 |
Why?
|
| Fetal Diseases | 1 | 2020 | 903 | 0.120 |
Why?
|
| Fontan Procedure | 1 | 2020 | 776 | 0.120 |
Why?
|
| Abruptio Placentae | 1 | 2015 | 118 | 0.120 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2009 | 740 | 0.120 |
Why?
|
| Bioprosthesis | 1 | 2018 | 597 | 0.120 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2015 | 173 | 0.120 |
Why?
|
| Uterus | 2 | 2012 | 711 | 0.110 |
Why?
|
| Hypertension | 1 | 2013 | 8479 | 0.110 |
Why?
|
| Metanephrine | 2 | 2009 | 26 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2019 | 1461 | 0.110 |
Why?
|
| Cardiomyopathies | 2 | 2019 | 1912 | 0.110 |
Why?
|
| Rheumatic Heart Disease | 1 | 2014 | 177 | 0.110 |
Why?
|
| Laparoscopy | 2 | 2002 | 2150 | 0.110 |
Why?
|
| Birth Weight | 1 | 2020 | 2069 | 0.100 |
Why?
|
| Mitral Valve Stenosis | 1 | 2014 | 376 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 570 | 0.100 |
Why?
|
| Fetus | 2 | 2016 | 1880 | 0.100 |
Why?
|
| Heart Valve Diseases | 1 | 2019 | 1074 | 0.100 |
Why?
|
| Electric Countershock | 1 | 2014 | 534 | 0.100 |
Why?
|
| Placenta | 1 | 2020 | 1699 | 0.100 |
Why?
|
| Anesthesia | 1 | 2022 | 1561 | 0.100 |
Why?
|
| Retrospective Studies | 9 | 2022 | 77460 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2016 | 4600 | 0.090 |
Why?
|
| Coronary Artery Disease | 2 | 2021 | 6486 | 0.090 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2011 | 250 | 0.090 |
Why?
|
| Thromboembolism | 1 | 2016 | 987 | 0.090 |
Why?
|
| Premature Birth | 1 | 2022 | 1721 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2023 | 8319 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 5 | 2020 | 1695 | 0.090 |
Why?
|
| Pregnancy, High-Risk | 1 | 2010 | 120 | 0.090 |
Why?
|
| Heart Block | 1 | 2011 | 410 | 0.090 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2014 | 710 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2018 | 1161 | 0.090 |
Why?
|
| Genital Neoplasms, Female | 1 | 1995 | 523 | 0.090 |
Why?
|
| Ventricular Function, Right | 1 | 2013 | 591 | 0.080 |
Why?
|
| Aortic Coarctation | 1 | 2011 | 281 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2019 | 2684 | 0.080 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 458 | 0.080 |
Why?
|
| Aortic Valve | 1 | 2018 | 1924 | 0.080 |
Why?
|
| Disease Management | 1 | 2019 | 2460 | 0.080 |
Why?
|
| Adult | 21 | 2022 | 214052 | 0.080 |
Why?
|
| Lymph Node Excision | 1 | 2014 | 1262 | 0.080 |
Why?
|
| Mastectomy | 1 | 2016 | 1793 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2018 | 1537 | 0.080 |
Why?
|
| Fetal Death | 3 | 2020 | 448 | 0.080 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 3666 | 0.080 |
Why?
|
| Puerperal Disorders | 1 | 2009 | 275 | 0.070 |
Why?
|
| Transposition of Great Vessels | 1 | 2011 | 588 | 0.070 |
Why?
|
| Thrombosis | 1 | 2020 | 2968 | 0.070 |
Why?
|
| Electrodes, Implanted | 1 | 2011 | 824 | 0.070 |
Why?
|
| Exercise | 1 | 2023 | 5615 | 0.070 |
Why?
|
| Mammaplasty | 1 | 2016 | 1204 | 0.070 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 1965 | 0.070 |
Why?
|
| Risk Factors | 9 | 2020 | 72296 | 0.070 |
Why?
|
| Pacemaker, Artificial | 1 | 2011 | 816 | 0.070 |
Why?
|
| Obstetric Labor, Premature | 2 | 2010 | 279 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 1223 | 0.060 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2011 | 489 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 3070 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2014 | 5984 | 0.050 |
Why?
|
| Infant | 2 | 2023 | 35134 | 0.050 |
Why?
|
| Colchicine | 1 | 2023 | 244 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2012 | 35425 | 0.050 |
Why?
|
| MEDLINE | 1 | 2001 | 125 | 0.050 |
Why?
|
| Infant Mortality | 2 | 2023 | 754 | 0.050 |
Why?
|
| Nifedipine | 1 | 2001 | 227 | 0.050 |
Why?
|
| Pregnancy, Prolonged | 1 | 2000 | 9 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2014 | 2758 | 0.050 |
Why?
|
| Uterine Contraction | 1 | 2001 | 93 | 0.050 |
Why?
|
| Comorbidity | 1 | 2015 | 10388 | 0.050 |
Why?
|
| Echocardiography | 3 | 2020 | 5099 | 0.050 |
Why?
|
| Leiomyoma | 1 | 2006 | 730 | 0.050 |
Why?
|
| Tachycardia | 2 | 2014 | 619 | 0.040 |
Why?
|
| Labor, Induced | 1 | 2000 | 146 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2022 | 648 | 0.040 |
Why?
|
| Heart Failure | 2 | 2021 | 10895 | 0.040 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1999 | 94 | 0.040 |
Why?
|
| Treatment Outcome | 7 | 2023 | 63107 | 0.040 |
Why?
|
| Taxoids | 1 | 2022 | 666 | 0.040 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2020 | 151 | 0.040 |
Why?
|
| Teratogens | 1 | 2019 | 112 | 0.040 |
Why?
|
| Chemoprevention | 1 | 2020 | 319 | 0.040 |
Why?
|
| Periodicity | 1 | 1999 | 364 | 0.040 |
Why?
|
| Electrocardiography | 3 | 2020 | 6442 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2009 | 571 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2000 | 590 | 0.040 |
Why?
|
| Radiography | 3 | 2014 | 7023 | 0.040 |
Why?
|
| Uterine Neoplasms | 1 | 2006 | 1513 | 0.040 |
Why?
|
| Medical Records | 1 | 2002 | 1413 | 0.030 |
Why?
|
| Standard of Care | 1 | 2019 | 564 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2016 | 40559 | 0.030 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2018 | 269 | 0.030 |
Why?
|
| Alkalosis, Respiratory | 1 | 2014 | 19 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2020 | 956 | 0.030 |
Why?
|
| International Cooperation | 1 | 2020 | 1420 | 0.030 |
Why?
|
| Young Adult | 6 | 2020 | 56429 | 0.030 |
Why?
|
| Methylene Blue | 1 | 2014 | 155 | 0.030 |
Why?
|
| Risk Assessment | 4 | 2020 | 23336 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2023 | 6459 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2282 | 0.030 |
Why?
|
| Stroke Volume | 2 | 2020 | 5006 | 0.030 |
Why?
|
| Breast Implants | 1 | 2016 | 387 | 0.030 |
Why?
|
| Cardiac Volume | 1 | 2013 | 210 | 0.030 |
Why?
|
| Adolescent | 5 | 2020 | 85779 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2020 | 3537 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2018 | 2110 | 0.030 |
Why?
|
| Dyspnea | 2 | 2009 | 1303 | 0.030 |
Why?
|
| Coloring Agents | 1 | 2014 | 566 | 0.020 |
Why?
|
| Recurrence | 1 | 2023 | 8340 | 0.020 |
Why?
|
| Aspirin | 1 | 2023 | 3283 | 0.020 |
Why?
|
| Endometriosis | 1 | 1999 | 839 | 0.020 |
Why?
|
| Menotropins | 1 | 1990 | 45 | 0.020 |
Why?
|
| Male | 4 | 2020 | 350115 | 0.020 |
Why?
|
| Medicaid | 1 | 2023 | 2737 | 0.020 |
Why?
|
| Perinatal Mortality | 1 | 2010 | 105 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2002 | 14723 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 174 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2011 | 363 | 0.020 |
Why?
|
| Fetofetal Transfusion | 1 | 2010 | 104 | 0.020 |
Why?
|
| Catecholamines | 1 | 2009 | 387 | 0.020 |
Why?
|
| Consensus | 1 | 2018 | 2960 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2009 | 2073 | 0.020 |
Why?
|
| United States | 3 | 2023 | 69872 | 0.020 |
Why?
|
| Acute Disease | 1 | 1999 | 7147 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2019 | 4196 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2018 | 2288 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2010 | 449 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2018 | 2926 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 1534 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1990 | 744 | 0.020 |
Why?
|
| Maternal Mortality | 1 | 2010 | 310 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 1990 | 869 | 0.020 |
Why?
|
| Stillbirth | 1 | 2010 | 346 | 0.020 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2010 | 235 | 0.020 |
Why?
|
| Maternal Age | 1 | 2010 | 802 | 0.020 |
Why?
|
| Parity | 1 | 2010 | 929 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 12961 | 0.020 |
Why?
|
| Pericardium | 1 | 2011 | 667 | 0.020 |
Why?
|
| Smoking | 1 | 2023 | 8987 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 39052 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2013 | 964 | 0.020 |
Why?
|
| Ovary | 1 | 1990 | 981 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 1995 | 1351 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2001 | 9955 | 0.020 |
Why?
|
| Chronic Disease | 1 | 1999 | 9145 | 0.010 |
Why?
|
| Safety Management | 1 | 2010 | 783 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3255 | 0.010 |
Why?
|
| Infertility, Female | 1 | 1990 | 788 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2009 | 1532 | 0.010 |
Why?
|
| Lung | 2 | 2014 | 9857 | 0.010 |
Why?
|
| Postpartum Period | 1 | 2009 | 1086 | 0.010 |
Why?
|
| Prognosis | 2 | 2014 | 29060 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 1995 | 2020 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 1257 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15078 | 0.010 |
Why?
|
| Headache | 1 | 2009 | 1226 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1990 | 2036 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15221 | 0.010 |
Why?
|
| Administration, Intravaginal | 1 | 2000 | 150 | 0.010 |
Why?
|
| Abortion, Spontaneous | 1 | 2006 | 544 | 0.010 |
Why?
|
| Pregnancy, Multiple | 1 | 2000 | 217 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11031 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13882 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40075 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1995 | 4839 | 0.010 |
Why?
|
| Length of Stay | 1 | 2011 | 6311 | 0.010 |
Why?
|
| Endosonography | 1 | 2000 | 610 | 0.010 |
Why?
|
| Middle Aged | 4 | 2018 | 213390 | 0.010 |
Why?
|
| Water | 1 | 2000 | 1395 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15297 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 20952 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 7914 | 0.010 |
Why?
|
| Animals | 1 | 2001 | 168768 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 7282 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1990 | 3873 | 0.000 |
Why?
|
| Estradiol | 1 | 1990 | 2020 | 0.000 |
Why?
|
| Fertilization in Vitro | 1 | 1990 | 1284 | 0.000 |
Why?
|
| Child | 1 | 2006 | 77709 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1990 | 11366 | 0.000 |
Why?
|